Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease

Systemic sclerosis (SSc) is a severe multi-organ disease with interstitial lung disease (ILD) being the major cause of death. While targeted therapies are emerging, biomarkers for sub-stratifying patients based on individual profiles are lacking. Herein, we investigated how levels of serum metabolit...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, C., Freiburghaus, K., Bovet, C., Schniering, J., Allanore, Y., Distler, O., Nakas, C., Maurer, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736572/
https://www.ncbi.nlm.nih.gov/pubmed/33318574
http://dx.doi.org/10.1038/s41598-020-78951-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736572/
https://www.ncbi.nlm.nih.gov/pubmed/33318574
http://dx.doi.org/10.1038/s41598-020-78951-6

Ejemplares similares